Parallel Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.4K | Sell |
|
|||||
|
2025
Q1 | $34.2K | Buy |
|
|||||
|
2024
Q4 | $54.2K | Buy |
|
|||||
|
2024
Q3 | $28K | Sell |
|
|||||
|
2024
Q2 | $31.9K | Buy |
|
|||||
|
2024
Q1 | $21.5K | Buy |
|
|||||
|
2023
Q4 | $3.99K | Buy |
|
|||||
|
2023
Q3 | $3.86K | Buy |
|
|||||
|
2023
Q2 | $664 | Sell |
|
|||||
|
2023
Q1 | $9.86K | Sell |
|
|||||
|
2022
Q4 | $37.4K | Buy |
|
|||||
|
2022
Q3 | $37K | Sell |
|
|||||
|
2022
Q2 | $38K | Sell |
|
|||||
|
2022
Q1 | $57K | Buy |
|
|||||
|
2021
Q4 | $34K | Buy |
|
|||||
|
2021
Q3 | $18K | Sell |
|
|||||
|
2021
Q2 | $35K | Buy |
|
|||||
|
2021
Q1 | $9K | Buy |
|
|||||
|
2020
Q4 | $9K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $0 | Buy |
|